Karkinos Healthcare conducts transformative digital cancer risk assessment and cervical cancer screening camp at Bangalore Central Prison

Karkinos Healthcare, a leading force in Oncological healthcare, collaborated with Bangalore-based NGO, Sakriya Charitable Trust, to organize a transformative Digital Cancer Risk Assessment and cervical cancer Screening camp at the Bangalore Central Prison. The five-day event witnessed an overwhelmingly positive response, impacting numerous individuals.

During the camp, a total of 1194 Digital Cancer Risk Assessments (CRA) were conducted, along with 113 HPV DNA tests, aiming to identify potential health risks, promote early detection, and enhance the overall well-being of the prison population. As per the data from National Prison Statistics India 2021, cancer has been identified as a major cause of Natural Deaths, emphasizing the importance of initiatives like this in addressing the healthcare needs of incarcerated individuals. The collaboration highlights the organizations’ shared commitment to improving the lives of marginalized communities.

Karkinos Healthcare and Sakriya Charitable Trust remain dedicated to raising awareness about cancer prevention, facilitating timely screenings, and extending their healthcare services to underserved populations. Sakriya Charitable Trust also empowers underprivileged women through impactful hygiene sessions, promoting health, dignity, and well-being.

“We would like to express our heartfelt gratitude to all the jail authority officers and volunteers for their unwavering support in making this Cancer Risk Assessment and Screening camp a resounding success. Their dedication and cooperation have been instrumental in ensuring that essential healthcare services reach the prison inmates. We are immensely grateful for their commitment to the well-being of the incarcerated individuals. Together, we are making a meaningful difference in their lives and promoting digital cancer risk assessment and women’s wellness programs in Karnataka.” – Rohith Venkateshan Chandrasekhar, Growth Manager, Women Wellness Programs at Karkinos Healthcare.

“We extend our heartfelt gratitude to Karkinos Healthcare for their invaluable contribution to conducting the cancer screening camp for prison inmates. The vulnerable population within the prison walls is at a higher risk of developing cancer, making this initiative all the more crucial. We appreciate Karkinos Healthcare’s commitment to addressing the healthcare needs of underserved communities and its dedication to improving the well-being of these individuals. Together, we are taking a significant step towards early detection and ensuring the overall health of the prison population.” – Dr. Harshawardhan, Chief Medical Officer at central prison Bangalore

This collaboration reflects their joint mission to create a positive impact on the health and well-being of incarcerated individuals. By providing essential cancer risk assessment and screening services, the initiative enables the identification of potential health concerns and the implementation of timely interventions. To highlight the importance of early detection in treating cancer, Karkinos Healthcare encourages people to come forward and avail themselves of the smooth and accessible Digital Cancer Risk Assessment which helps in timely treatment of cancer, if detected.

About Karkinos Healthcare:

Karkinos Healthcare is a technology-driven oncology-focused managed healthcare platform for the early detection and diagnosis of common cancers. The organization espouses the use of a distributed cancer care network while working with a network of healthcare institutions and domain experts within the ecosystem, with an aim to provide comprehensive cancer care closer to individuals’ homes.

Tata Group, Reliance Industries, Mayo Clinic, and Rakuten Medical Inc. are among the world’s leading organizations that have invested in Karkinos Healthcare. The company has also partnered with Tata Memorial Hospital, Guys, and St Thomas NHS Foundation Trust (UK), and has inked several research collaborations with leading academic institutions in the United States to stay on the cutting edge of oncology treatment and care.